06/08/2026
New publication in Cornea: "Osimertinib-Associated Benign Ocular Hyperpigmentation: A Case Report"
Delighted to share this case report describing a previously unreported ocular finding: bilateral conjunctival, caruncular, and corneal epithelial hyperpigmentation in a patient on long-term osimertinib for EGFR-mutated non-small-cell lung cancer. As osimertinib has become first-line therapy for this cancer, recognising this benign presentation and differentiating it from primary acquired melanosis (which carries malignant potential) is clinically important for both ophthalmologists and oncology teams.
Huge congratulations to all my co-authors, and particular thanks to:
👏 Dr. Nuhansi Wijesinghe, a junior doctor early in her career, who led this case report with real diligence and clinical curiosity.
👏 Ann Chung, whose contribution as part of her MPhil training reflects exactly the kind of rigorous, evidence-based thinking we want to nurture in the next generation of clinician-academics.
Academic writing does two things at once: it shares knowledge that helps other clinicians recognise and manage what they see in clinic, and it builds the skills and confidence of those who will carry the field forward. Watching junior colleagues take a clinical observation through to publication is one of the most rewarding parts of academic medicine.
